|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
WO2008081008A1
(en)
*
|
2007-01-05 |
2008-07-10 |
University Of Zurich |
Method of providing disease-specific binding molecules and targets
|
|
CN101965365A
(zh)
*
|
2007-10-19 |
2011-02-02 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
CN102936287B
(zh)
|
2008-02-08 |
2015-09-09 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
EP2321348A2
(en)
*
|
2008-07-09 |
2011-05-18 |
University of Zürich |
Method of promoting neurogenesis
|
|
CN102317316B
(zh)
|
2008-12-19 |
2014-08-13 |
帕尼玛制药股份公司 |
人抗α突触核蛋白自身抗体
|
|
CN102459335B
(zh)
|
2009-04-17 |
2015-11-25 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
JP5599454B2
(ja)
|
2009-08-06 |
2014-10-01 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
TWI622402B
(zh)
|
2010-02-24 |
2018-05-01 |
免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
US20150018408A1
(en)
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
AU2012205718B2
(en)
|
2011-01-10 |
2017-07-06 |
The Regents Of The University Of Michigan |
Stem cell factor inhibitor
|
|
EP3604339B1
(en)
|
2011-01-14 |
2021-03-10 |
The Regents Of The University Of California |
Therapeutic antibodies against ror-1 protein and methods for use of same
|
|
BR112013025415B1
(pt)
*
|
2011-04-01 |
2021-03-16 |
Immunogen, Inc |
uso de um imunoconjugado antirreceptor de folato 1 (folr1)
|
|
SI2723379T1
(sl)
|
2011-06-23 |
2019-03-29 |
Biogen International Neuroscience Gmbh |
Molekule, ki se vežejo ma anti alfa-sinuklein
|
|
GB201110938D0
(en)
*
|
2011-06-27 |
2011-08-10 |
Iti Scotland Ltd |
Compounds
|
|
EP2756002A4
(en)
*
|
2011-09-16 |
2015-04-08 |
Univ Texas |
COMPOSITIONS AND METHODS RELATED TO THE REPAIR OF DNA DAMAGES
|
|
US9200073B2
(en)
*
|
2012-08-31 |
2015-12-01 |
Immunogen, Inc. |
Diagnostic assays and kits for detection of folate receptor 1
|
|
CA2894879A1
(en)
*
|
2012-12-19 |
2014-06-26 |
Amplimmune, Inc. |
B7-h4 specific antibodies, and compositions and methods of use thereof
|
|
US9534044B2
(en)
*
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
|
CA2921652A1
(en)
*
|
2013-08-21 |
2015-02-26 |
Manuel A. Riquelme |
Compositions and methods for targeting connexin hemichannels
|
|
CN113150145B
(zh)
|
2013-08-30 |
2025-02-14 |
伊缪诺金公司 |
用于检测叶酸受体1的抗体和测定
|
|
US20160264684A1
(en)
*
|
2013-10-10 |
2016-09-15 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US9416197B2
(en)
|
2013-11-01 |
2016-08-16 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease
|
|
EP3105251A4
(en)
*
|
2014-02-10 |
2017-11-15 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
|
|
US10401368B2
(en)
|
2014-03-20 |
2019-09-03 |
Pdl Biopharma, Inc. |
Antibodies and methods for the detection of cell death
|
|
CA2941029C
(en)
*
|
2014-04-10 |
2021-02-16 |
Obi Pharma Inc. |
Antibodies, pharmaceutical compositions and uses thereof
|
|
MD4733C1
(ro)
|
2014-08-19 |
2021-07-31 |
Merck Sharp & Dohme Corp |
Anticorpi anti-TIGIT
|
|
BR112017003263A2
(pt)
*
|
2014-09-16 |
2017-11-28 |
Ovascience Inc |
anticorpos anti-vasa, e métodos de produção e utilização dos mesmos
|
|
JP2017536102A
(ja)
*
|
2014-10-16 |
2017-12-07 |
ジェネンテック， インコーポレイテッド |
抗アルファ−シヌクレイン抗体及び使用方法
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
FI3218005T3
(fi)
|
2014-11-12 |
2023-03-31 |
Seagen Inc |
Glykaanin kanssa vuorovaikutteisia yhdisteitä ja käyttömenetelmiä
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
ES2870983T3
(es)
*
|
2014-12-19 |
2021-10-28 |
Univ Nantes |
Anticuerpos anti-IL-34
|
|
US10654917B2
(en)
*
|
2015-01-29 |
2020-05-19 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
EP3262070A4
(en)
|
2015-02-24 |
2018-07-25 |
Rpeptide, LLC |
Anti-amyloid-beta antibodies
|
|
US10517948B2
(en)
|
2015-03-11 |
2019-12-31 |
The Board Of Regents Of The University Of Texas System |
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
|
|
WO2016149116A1
(en)
*
|
2015-03-13 |
2016-09-22 |
University Of Maryland, Baltimore |
Antibodies targeting s100b and methods of use
|
|
WO2016160618A2
(en)
*
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
|
EP4019552A1
(en)
*
|
2015-06-10 |
2022-06-29 |
National Research Council of Canada |
Carbonic anhydrase ix-specific antibodies and uses thereof
|
|
WO2016205566A1
(en)
*
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
CN108290936B
(zh)
*
|
2015-08-14 |
2022-07-12 |
默沙东公司 |
抗tigit抗体
|
|
CN117510633A
(zh)
|
2015-09-02 |
2024-02-06 |
伊缪泰普有限公司 |
抗lag-3抗体
|
|
CN116440279B
(zh)
|
2015-09-17 |
2026-02-24 |
伊缪诺金公司 |
包含抗folr1免疫缀合物的治疗组合
|
|
KR102776187B1
(ko)
|
2015-11-09 |
2025-03-07 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에서의 n-말단 에피토프 및 이에 형태적으로-선택적인 항체
|
|
AU2016353553B2
(en)
|
2015-11-09 |
2022-01-20 |
The University Of British Columbia |
Amyloid beta epitopes and antibodies thereto
|
|
EP3374381A4
(en)
|
2015-11-09 |
2019-05-15 |
The University Of British Columbia |
EPITOPES IN THE AMYLOID-BETA MEDIUM REGION AND CONFORMITY-SELECTIVE ANTIBODIES THEREOF
|
|
CA3002097A1
(en)
|
2015-11-12 |
2017-05-18 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US10537633B2
(en)
|
2016-03-04 |
2020-01-21 |
Jn Biosciences Llc |
Antibodies to TIGIT
|
|
WO2017160587A1
(en)
*
|
2016-03-16 |
2017-09-21 |
Abeome Corporation |
Neutralizing monoclonal antibodies to il-25 and uses thereof
|
|
US20180362660A1
(en)
*
|
2016-05-09 |
2018-12-20 |
Schickwann Tsai |
Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
|
|
BR112018076247A2
(pt)
|
2016-06-16 |
2019-03-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
anticorpos monoclonais quiméricos e humanizados para cd81
|
|
CN109476729A
(zh)
*
|
2016-07-18 |
2019-03-15 |
英属哥伦比亚大学 |
淀粉样蛋白β的抗体
|
|
JOP20170154B1
(ar)
*
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
WO2018094143A1
(en)
|
2016-11-17 |
2018-05-24 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
EP3544628A4
(en)
*
|
2016-11-23 |
2020-11-18 |
Immunoah Therapeutics, Inc. |
4-1BB BINDING PROTEINS AND THEIR USES
|
|
CN106749657A
(zh)
*
|
2016-12-13 |
2017-05-31 |
中国农业科学院哈尔滨兽医研究所 |
一种抗体信号肽及其应用
|
|
EP3585403A4
(en)
*
|
2017-02-22 |
2020-12-09 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CHEMERICAL ANTIGENIC RECEPTORS BINDING TO TIM3
|
|
CN110392697A
(zh)
*
|
2017-03-02 |
2019-10-29 |
国家医疗保健研究所 |
对nectin-4具有特异性的抗体及其用途
|
|
WO2018160909A1
(en)
|
2017-03-03 |
2018-09-07 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US11608384B2
(en)
*
|
2017-04-05 |
2023-03-21 |
Xdcexplorer (Shanghai) Co., Ltd. |
Humanized anti-TPBG antibody, preparation method therefor, conjugate thereof, and applications
|
|
EP3655026A4
(en)
|
2017-07-17 |
2021-07-28 |
Janssen Biotech, Inc. |
ANTIGBINDING REGIONS AGAINST FIBRONECTIN TYPE III DOMAINS AND METHOD OF USING THEREOF
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
CN118370815A
(zh)
|
2017-08-22 |
2024-07-23 |
渤健马萨诸塞州股份有限公司 |
含有抗β淀粉样蛋白抗体的药物组合物
|
|
WO2019217833A1
(en)
*
|
2018-05-10 |
2019-11-14 |
Abvision, Inc. |
Monoclonal antibodies activating cd40 and uses thereof
|
|
WO2019231957A1
(en)
*
|
2018-05-30 |
2019-12-05 |
National Health Research Institutes |
Anti-abeta antibodies and uses thereof
|
|
DK3806903T5
(da)
*
|
2018-06-14 |
2024-08-19 |
2Seventy Bio Inc |
Cd79a kimæriske antigenreceptorer
|
|
CN112955548B
(zh)
*
|
2018-07-09 |
2023-11-24 |
普众发现医药科技(上海)有限公司 |
叶酸受体α特异性抗体
|
|
BR112021004553A2
(pt)
*
|
2018-09-17 |
2021-06-08 |
Abcuro, Inc. |
anticorpos anti-klrg1
|
|
WO2020156335A1
(zh)
*
|
2019-01-29 |
2020-08-06 |
上海交通大学 |
一种嵌合抗原受体及其应用
|
|
WO2020160156A2
(en)
|
2019-01-30 |
2020-08-06 |
Immutics, Inc. |
Anti-gal3 antibodies and uses thereof
|
|
EP3935086A4
(en)
*
|
2019-03-02 |
2022-11-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic antigen binding proteins specific for cd93 and methods of use thereof
|
|
JOP20210265A1
(ar)
|
2019-03-26 |
2023-01-30 |
Janssen Pharmaceutica Nv |
الأجسام المضادة لبيروغلوتامات أميلويد بيتا واستخداماتها
|
|
CN110343180B
(zh)
*
|
2019-07-25 |
2021-03-30 |
北京免疫方舟医药科技有限公司 |
抗ctla-4抗体及其应用
|
|
US12352719B2
(en)
|
2019-09-20 |
2025-07-08 |
KYCERA AVX Components Corporation |
Somatic cell-based electrical biosensor
|
|
WO2021138380A2
(en)
*
|
2019-12-30 |
2021-07-08 |
University Of Louisville Research Foundation, Inc. |
Virus-like particle binding agents, related compositions, and related methods
|
|
CN111793136A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种nmp22抗体对及其应用
|
|
CN111808191A
(zh)
*
|
2020-05-11 |
2020-10-23 |
廊坊天光生物技术有限公司 |
一种用于检测血清中vegf含量的抗体对及其用途
|
|
WO2021231982A1
(en)
*
|
2020-05-14 |
2021-11-18 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
EP4157338A4
(en)
|
2020-05-26 |
2024-11-13 |
TrueBinding, Inc. |
METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
|
|
MX2022015157A
(es)
|
2020-06-02 |
2023-01-16 |
Arcus Biosciences Inc |
Anticuerpos para tigit.
|
|
CA3183835A1
(en)
|
2020-06-25 |
2021-12-30 |
Jeanne E. Baker |
High affinity antibodies targeting tau phosphorylated at serine 413
|
|
KR20230039734A
(ko)
|
2020-07-23 |
2023-03-21 |
오타이르 프로테나 리미티드 |
항-Aβ 항체
|
|
WO2022031680A1
(en)
*
|
2020-08-04 |
2022-02-10 |
Exelixis, Inc. |
Cd47 binding agents and uses thereof
|
|
JP7634082B2
(ja)
*
|
2020-08-18 |
2025-02-20 |
オメロス コーポレーション |
補体因子ｄを検出するためのモノクローナル抗体、組成物、および方法
|
|
CN112778419A
(zh)
*
|
2021-02-01 |
2021-05-11 |
重庆中元汇吉生物技术有限公司 |
抗ck-mb的抗体或其抗原结合部分及其应用
|
|
WO2022174103A2
(en)
*
|
2021-02-11 |
2022-08-18 |
The Regents Of The University Of California |
Monoclonal antibodies specific for human ror1
|
|
CN113075398A
(zh)
*
|
2021-03-23 |
2021-07-06 |
中国医学科学院输血研究所 |
一种血浆中特异性IgG抗体的定量测定方法
|
|
US20250180551A1
(en)
*
|
2021-10-26 |
2025-06-05 |
Bach Diagnostics Inc. |
Lateral flow assay for the diagnosis of dermatomycosis
|
|
JP2025537193A
(ja)
*
|
2022-11-08 |
2025-11-14 |
フェインズ セラピューティクス，インコーポレーテッド |
抗５ｔ４抗体及びその使用
|
|
US12534540B2
(en)
*
|
2023-01-23 |
2026-01-27 |
Clemson University Research Foundation |
CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
US20240352102A1
(en)
*
|
2023-01-27 |
2024-10-24 |
The United States Government As Represented By The Department Of Veterans Affairs |
Compositions for treating tauopathies and methods of use thereof
|
|
AU2024227909A1
(en)
*
|
2023-02-28 |
2025-08-14 |
Mayo Foundation For Medical Education And Research |
Molecules that bind to b-cell activating factor receptor polypeptides
|
|
CN119306826B
(zh)
*
|
2023-07-11 |
2025-06-20 |
东莞市朋志生物科技有限公司 |
抗白介素-6抗体、检测白介素-6的试剂和试剂盒
|
|
CN121773130A
(zh)
*
|
2023-08-25 |
2026-03-31 |
康诺亚生物医药科技（成都）有限公司 |
阿尔茨海默病治疗剂的开发和应用
|
|
WO2026060081A1
(en)
*
|
2024-09-12 |
2026-03-19 |
Denali Therapeutics Inc. |
Anti-amyloid beta antibodies and methods of use
|
|
CN119613538B
(zh)
*
|
2024-12-12 |
2025-10-17 |
浙江大学医学院附属第一医院(浙江省第一医院) |
抗h10亚型流感病毒血凝素蛋白中和性单克隆抗体1e10及其应用
|
|
CN120209138B
(zh)
*
|
2025-05-29 |
2025-10-03 |
杭州广科安德生物科技有限公司 |
Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用
|
|
CN121319156A
(zh)
*
|
2025-11-19 |
2026-01-13 |
北京中科蓝玉生物科技有限公司 |
抗猪繁殖与呼吸综合征病毒gp3蛋白的抗体及其应用
|